{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:11:52Z","timestamp":1789373512827,"version":"build-2803163510"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0596-8","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T06:50:53Z","timestamp":1436856653000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Development of patient-derived xenograft models from a spontaneously immortal low-grade meningioma cell line, KCI-MENG1"],"prefix":"10.1186","volume":"13","author":[{"given":"Sharon K","family":"Michelhaugh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R","family":"Guastella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil V","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prahlad","family":"Parajuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aamir","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amro","family":"Aboukameel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Kiousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M","family":"Zitron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah A","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Polin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazlul H","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliccia","family":"Bollig-Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,15]]},"reference":[{"issue":"Suppl 5","key":"596_CR1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","volume":"14","author":"TA Dolecek","year":"2012","unstructured":"Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009. Neuro Oncol 14(Suppl 5):v1\u2013v49. doi: 10.1093\/neuonc\/nos218","journal-title":"Neuro Oncol"},{"issue":"3","key":"596_CR2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","volume":"99","author":"C Mawrin","year":"2010","unstructured":"Mawrin C, Perry A (2010) Pathological classification and molecular genetics of meningiomas. J Neurooncol 99(3):379\u2013391. doi: 10.1007\/s11060-010-0342-2","journal-title":"J Neurooncol"},{"key":"596_CR3","volume-title":"WHO classification of tumours of the central nervous system","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) (2007) WHO classification of tumours of the central nervous system, 2007th edn. IARC, Lyon","edition":"2007"},{"issue":"3","key":"596_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.clineuro.2009.12.011","volume":"112","author":"GA Alexiou","year":"2010","unstructured":"Alexiou GA, Gogou P, Markoula S, Kyritsis AP (2010) Management of meningiomas. Clin Neurol Neurosurg 112(3):177\u2013182. doi: 10.1016\/j.clineuro.2009.12.011","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"596_CR5","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.3171\/2013.10.FOCUS13341","volume":"35","author":"AA Moazzam","year":"2013","unstructured":"Moazzam AA, Wagle N, Zada G (2013) Recent developments in chemotherapy for meningiomas: a review. Neurosurg Focus 35(6):E18. doi: 10.3171\/2013.10.FOCUS13341","journal-title":"Neurosurg Focus"},{"issue":"3","key":"596_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1227\/00006123-199009000-00008","volume":"27","author":"WH Lee","year":"1990","unstructured":"Lee WH (1990) Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee. Neurosurgery 27(3):389\u2013395 (discussion 96)","journal-title":"Neurosurgery"},{"issue":"1","key":"596_CR7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF01058456","volume":"23","author":"T Yazaki","year":"1995","unstructured":"Yazaki T, Takamiya Y, Costello PC, Mineta T, Menon AG, Rabkin SD et al (1995) Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470. J Neurooncol 23(1):23\u201329","journal-title":"J Neurooncol"},{"issue":"11","key":"596_CR8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/1097-0142(19891201)64:11<2243::AID-CNCR2820641110>3.0.CO;2-S","volume":"64","author":"K Tanaka","year":"1989","unstructured":"Tanaka K, Sato C, Maeda Y, Koike M, Matsutani M, Yamada K et al (1989) Establishment of a human malignant meningioma cell line with amplified c-myc oncogene. Cancer 64(11):2243\u20132249","journal-title":"Cancer"},{"issue":"4","key":"596_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1749-0774.2004.tb00045.x","volume":"17","author":"I Ishiwata","year":"2004","unstructured":"Ishiwata I, Ishiwata C, Ishiwata E, Sato Y, Kiguchi K, Tachibana T et al (2004) In vitro culture of various typed meningiomas and characterization of a human malignant meningioma cell line (HKBMM). Hum Cell 17(4):211\u2013217","journal-title":"Hum Cell"},{"issue":"4","key":"596_CR10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1227\/01.NEU.0000255397.00410.8F","volume":"60","author":"TG Cargioli","year":"2007","unstructured":"Cargioli TG, Ugur HC, Ramakrishna N, Chan J, Black PM, Carroll RS (2007) Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery 60(4):750\u2013759 (discussion 9\u201360)","journal-title":"Neurosurgery"},{"issue":"9","key":"596_CR11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/labinvest.3700307","volume":"85","author":"S Puttmann","year":"2005","unstructured":"Puttmann S, Senner V, Braune S, Hillmann B, Exeler R, Rickert CH et al (2005) Establishment of a benign meningioma cell line by hTERT-mediated immortalization. Lab Invest 85(9):1163\u20131171. doi: 10.1038\/labinvest.3700307","journal-title":"Lab Invest"},{"issue":"2","key":"596_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-005-9076-y","volume":"78","author":"GS Baia","year":"2006","unstructured":"Baia GS, Slocum AL, Hyer JD, Misra A, Sehati N, VandenBerg SR et al (2006) A genetic strategy to overcome the senescence of primary meningioma cell cultures. J Neurooncol 78(2):113\u2013121. doi: 10.1007\/s11060-005-9076-y","journal-title":"J Neurooncol"},{"issue":"11","key":"596_CR13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1593\/neo.08642","volume":"10","author":"K Striedinger","year":"2008","unstructured":"Striedinger K, VandenBerg SR, Baia GS, McDermott MW, Gutmann DH, Lal A (2008) The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP. Neoplasia 10(11):1204\u20131212","journal-title":"Neoplasia"},{"issue":"5","key":"596_CR14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3171\/jns.2000.92.5.0832","volume":"92","author":"M Simon","year":"2000","unstructured":"Simon M, Park TW, Leuenroth S, Hans VH, Loning T, Schramm J (2000) Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J Neurosurg 92(5):832\u2013840","journal-title":"J Neurosurg"},{"issue":"6","key":"596_CR15","first-page":"1571","volume":"18","author":"L Maes","year":"2007","unstructured":"Maes L, Van Neste L, Van Damme K, Kalala JP, De Ridder L, Bekaert S et al (2007) Relation between telomerase activity, hTERT and telomere length for intracranial tumours. Oncol Rep 18(6):1571\u20131576","journal-title":"Oncol Rep"},{"issue":"1","key":"596_CR16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1750-3639.2007.00105.x","volume":"18","author":"M Kalamarides","year":"2008","unstructured":"Kalamarides M, Stemmer-Rachamimov AO, Takahashi M, Han ZY, Chareyre F, Niwa-Kawakita M et al (2008) Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol 18(1):62\u201370. doi: 10.1111\/j.1750-3639.2007.00105.x","journal-title":"Brain Pathol"},{"issue":"36","key":"596_CR17","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/onc.2012.436","volume":"32","author":"M Peyre","year":"2013","unstructured":"Peyre M, Stemmer-Rachamimov A, Clermont-Taranchon E, Quentin S, El-Taraya N, Walczak C et al (2013) Meningioma progression in mice triggered by Nf2 and Cdkn2ab inactivation. Oncogene 32(36):4264\u20134272. doi: 10.1038\/onc.2012.436","journal-title":"Oncogene"},{"issue":"7527","key":"596_CR18","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature13992","volume":"515","author":"F Yue","year":"2014","unstructured":"Yue F, Cheng Y, Breschi A, Vierstra J, Wu W, Ryba T et al (2014) A comparative encyclopedia of DNA elements in the mouse genome. Nature 515(7527):355\u2013364. doi: 10.1038\/nature13992","journal-title":"Nature"},{"issue":"17","key":"596_CR19","doi-asserted-by":"crossref","first-page":"5315","DOI":"10.1158\/0008-5472.CAN-13-1069","volume":"73","author":"D Siolas","year":"2013","unstructured":"Siolas D, Hannon GJ (2013) Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res 73(17):5315\u20135319. doi: 10.1158\/0008-5472.CAN-13-1069","journal-title":"Cancer Res"},{"issue":"4","key":"596_CR20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/jnen\/63.4.275","volume":"63","author":"K Lamszus","year":"2004","unstructured":"Lamszus K (2004) Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 63(4):275\u2013286","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"596_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11060-004-2749-0","volume":"70","author":"A Perry","year":"2004","unstructured":"Perry A, Gutmann DH, Reifenberger G (2004) Molecular pathogenesis of meningiomas. J Neurooncol 70(2):183\u2013202","journal-title":"J Neurooncol"},{"issue":"3\u20134","key":"596_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000056986","volume":"93","author":"KD Zang","year":"2001","unstructured":"Zang KD (2001) Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 93(3\u20134):207\u2013220","journal-title":"Cytogenet Cell Genet"},{"issue":"1","key":"596_CR23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1601-5223.1972.tb01017.x","volume":"71","author":"J Mark","year":"1972","unstructured":"Mark J, Levan G, Mitelman F (1972) Identification by fluorescence of the G chromosome lost in human meningomas. Hereditas 71(1):163\u2013168","journal-title":"Hereditas"},{"issue":"2","key":"596_CR24","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00273305","volume":"14","author":"H Zankl","year":"1972","unstructured":"Zankl H, Zang KD (1972) Cytological and cytogenetical studies on brain tumors. 4. Identification of the missing G chromosome in human meningiomas as no. 22 by fluorescence technique. Humangenetik 14(2):167\u2013169","journal-title":"Humangenetik"},{"issue":"5","key":"596_CR25","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2011.2.FOCUS1116","volume":"30","author":"W Choy","year":"2011","unstructured":"Choy W, Kim W, Nagasawa D, Stramotas S, Yew A, Gopen Q et al (2011) The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. Neurosurg Focus 30(5):E6. doi: 10.3171\/2011.2.FOCUS1116","journal-title":"Neurosurg Focus"},{"issue":"2","key":"596_CR26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","volume":"101","author":"O Al-Mefty","year":"2004","unstructured":"Al-Mefty O, Kadri PA, Pravdenkova S, Sawyer JR, Stangeby C, Husain M (2004) Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings. J Neurosurg 101(2):210\u2013218","journal-title":"J Neurosurg"},{"issue":"2","key":"596_CR27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2990.2011.01222.x","volume":"38","author":"M Jansen","year":"2012","unstructured":"Jansen M, Mohapatra G, Betensky RA, Keohane C, Louis DN (2012) Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol Appl Neurobiol 38(2):213\u2013219. doi: 10.1111\/j.365-2990.011.01222.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"596_CR28","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1593\/neo.121398","volume":"15","author":"A Christodoulidou","year":"2013","unstructured":"Christodoulidou A, Raftopoulou C, Chiourea M, Papaioannou GK, Hoshiyama H, Wright WE et al (2013) The roles of telomerase in the generation of polyploidy during neoplastic cell growth. Neoplasia 15(2):156\u2013168","journal-title":"Neoplasia"},{"issue":"4","key":"596_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4161\/cbt.23624","volume":"14","author":"IM Zitron","year":"2013","unstructured":"Zitron IM, Kamson DO, Kiousis S, Juhasz C, Mittal S (2013) In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1. Cancer Biol Ther 14(4):333\u2013339","journal-title":"Cancer Biol Ther"},{"key":"596_CR30","author":"E Bosny\u00e1k","year":"2015","unstructured":"Bosny\u00e1k E, Kamson DO, Guastella AR, Varadarajan K, Robinette NL, Kupsky WJ et al (2015) Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas. Neuro Oncol. doi: 10.1093\/neuonc\/nov098","journal-title":"Neuro Oncol"},{"key":"596_CR31","volume-title":"ACT cytogenetics laboratory manual","author":"M Barch","year":"1991","unstructured":"Barch M (1991) ACT cytogenetics laboratory manual, 2nd edn. Raven Press NYC, New York","edition":"2"},{"key":"596_CR32","unstructured":"Shaffer LG, McGowan-Jordan J, Schmid M (eds) (2013) ISCN 2013: an international system for human cytogenetic nomenclature, 1st edn. S. Karger AG, Basel"},{"issue":"3","key":"596_CR33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrc1299","volume":"4","author":"PA Futreal","year":"2004","unstructured":"Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R et al (2004) A census of human cancer genes. Nat Rev Cancer 4(3):177\u2013183. doi: 10.1038\/nrc1299","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"596_CR34","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3171\/jns.1995.82.5.0864","volume":"82","author":"JC Tsai","year":"1995","unstructured":"Tsai JC, Goldman CK, Gillespie GY (1995) Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82(5):864\u2013873","journal-title":"J Neurosurg"},{"issue":"10","key":"596_CR35","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nrg1692","volume":"6","author":"MR Speicher","year":"2005","unstructured":"Speicher MR, Carter NP (2005) The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet 6(10):782\u2013792. doi: 10.1038\/nrg1692","journal-title":"Nat Rev Genet"},{"issue":"1","key":"596_CR36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1227\/00006123-199207000-00002","volume":"31","author":"M Kallio","year":"1992","unstructured":"Kallio M, Sankila R, Hakulinen T, Jaaskelainen J (1992) Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 31(1):2\u201312","journal-title":"Neurosurgery"},{"issue":"1","key":"596_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3171\/jns.1985.62.1.0018","volume":"62","author":"RO Mirimanoff","year":"1985","unstructured":"Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL (1985) Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 62(1):18\u201324","journal-title":"J Neurosurg"},{"issue":"9","key":"596_CR38","first-page":"2046","volume":"85","author":"A Perry","year":"1999","unstructured":"Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC (1999) \u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85(9):2046\u20132056","journal-title":"Cancer"},{"issue":"2","key":"596_CR39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1005853720926","volume":"37","author":"TW Dziuk","year":"1998","unstructured":"Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS et al (1998) Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37(2):177\u2013188","journal-title":"J Neurooncol"},{"issue":"3","key":"596_CR40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0090-3019(86)90233-8","volume":"25","author":"J Jaaskelainen","year":"1986","unstructured":"Jaaskelainen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25(3):233\u2013242","journal-title":"Surg Neurol"},{"issue":"2","key":"596_CR41","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3171\/jns.1994.80.2.0195","volume":"80","author":"BJ Goldsmith","year":"1994","unstructured":"Goldsmith BJ, Wara WM, Wilson CB, Larson DA (1994) Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80(2):195\u2013201","journal-title":"J Neurosurg"},{"issue":"3","key":"596_CR42","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ijrobp.2011.08.010","volume":"83","author":"S Adeberg","year":"2012","unstructured":"Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A et al (2012) Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas\u2014clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83(3):859\u2013864. doi: 10.1016\/j.ijrobp.2011.08.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"596_CR43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/neuonc\/nou025","volume":"16","author":"G Kaur","year":"2014","unstructured":"Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ et al (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 16(5):628\u2013636. doi: 10.1093\/neuonc\/nou025","journal-title":"Neuro Oncol"},{"issue":"3","key":"596_CR44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.surneu.2007.06.031","volume":"70","author":"BT Ragel","year":"2008","unstructured":"Ragel BT, Couldwell WT, Gillespie DL, Wendland MM, Whang K, Jensen RL (2008) A comparison of the cell lines used in meningioma research. Surg Neurol 70(3):295\u2013307. doi: 10.1016\/j.surneu.2007.06.031","journal-title":"Surg Neurol"},{"issue":"2","key":"596_CR45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3171\/jns.2006.105.2.163","volume":"105","author":"S Pravdenkova","year":"2006","unstructured":"Pravdenkova S, Al-Mefty O, Sawyer J, Husain M (2006) Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas. J Neurosurg 105(2):163\u2013173. doi: 10.3171\/jns.2006.105.2.163","journal-title":"J Neurosurg"},{"key":"596_CR46","unstructured":"Van Marck VL, Bracke ME (2000) Epithelial\u2013mesenchymal transitions in human cancer. Madame Curie Bioscience Database [Internet]. Landes Bioscience, Austin"},{"issue":"9","key":"596_CR47","doi-asserted-by":"crossref","first-page":"e46053","DOI":"10.1371\/journal.pone.0046053","volume":"7","author":"M Nagaishi","year":"2012","unstructured":"Nagaishi M, Nobusawa S, Tanaka Y, Ikota H, Yokoo H, Nakazato Y (2012) Slug, twist, and E-cadherin as immunohistochemical biomarkers in meningeal tumors. PLoS One 7(9):e46053. doi: 10.1371\/journal.pone.0046053","journal-title":"PLoS One"},{"issue":"3","key":"596_CR48","doi-asserted-by":"crossref","first-page":"e57692","DOI":"10.1371\/journal.pone.0057692","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Liu G, Kang Y, Dong Z, Qian Q, Ma X (2013) N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS One 8(3):e57692. doi: 10.1371\/journal.pone.0057692","journal-title":"PLoS One"},{"issue":"12 Pt 1","key":"596_CR49","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-0578-03","volume":"10","author":"S Nakajima","year":"2004","unstructured":"Nakajima S, Doi R, Toyoda E, Tsuji S, Wada M, Koizumi M et al (2004) N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 10(12 Pt 1):4125\u20134133. doi: 10.1158\/1078-0432.CCR-0578-03","journal-title":"Clin Cancer Res"},{"key":"596_CR50","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2741\/e427","volume":"4","author":"N Pecina-Slaus","year":"2012","unstructured":"Pecina-Slaus N, Cicvara-Pecina T, Kafka A (2012) Epithelial-to-mesenchymal transition: possible role in meningiomas. Front Biosci (Elite Ed) 4:889\u2013896","journal-title":"Front Biosci (Elite Ed)"},{"issue":"2","key":"596_CR51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molmed.2012.11.006","volume":"19","author":"S Mocellin","year":"2013","unstructured":"Mocellin S, Pooley KA, Nitti D (2013) Telomerase and the search for the end of cancer. Trends Mol Med 19(2):125\u2013133. doi: 10.1016\/j.molmed.2012.11.006","journal-title":"Trends Mol Med"},{"key":"596_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1101\/sqb.2005.70.032","volume":"70","author":"T Lange De","year":"2005","unstructured":"De Lange T (2005) Telomere-related genome instability in cancer. Cold Spring Harb Symp Quant Biol 70:197\u2013204. doi: 10.1101\/sqb.2005.70.032","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"10","key":"596_CR53","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1097-0142(20001115)89:10<2092::AID-CNCR9>3.0.CO;2-N","volume":"89","author":"HJ Chen","year":"2000","unstructured":"Chen HJ, Liang CL, Lu K, Lin JW, Cho CL (2000) Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas. Cancer 89(10):2092\u20132098","journal-title":"Cancer"},{"issue":"4","key":"596_CR54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S0046-8177(97)90029-0","volume":"28","author":"LA Langford","year":"1997","unstructured":"Langford LA, Piatyszek MA, Xu R, Schold SC Jr, Wright WE, Shay JW (1997) Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 28(4):416\u2013420","journal-title":"Hum Pathol"},{"issue":"2","key":"596_CR55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3171\/jns.2004.100.2.0303","volume":"100","author":"P Leuraud","year":"2004","unstructured":"Leuraud P, Dezamis E, Aguirre-Cruz L, Taillibert S, Lejeune J, Robin E et al (2004) Prognostic value of allelic losses and telomerase activity in meningiomas. J Neurosurg 100(2):303\u2013309","journal-title":"J Neurosurg"},{"issue":"6","key":"596_CR56","first-page":"1601","volume":"39","author":"S Urbschat","year":"2011","unstructured":"Urbschat S, Rahnenfuhrer J, Henn W, Feiden W, Wemmert S, Linsler S et al (2011) Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence. Int J Oncol 39(6):1601\u20131608. doi: 10.3892\/ijo.2011.1199","journal-title":"Int J Oncol"},{"issue":"2","key":"596_CR57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/bpa.12110","volume":"24","author":"S Goutagny","year":"2014","unstructured":"Goutagny S, Nault JC, Mallet M, Henin D, Rossi JZ, Kalamarides M (2014) High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression. Brain Pathol 24(2):184\u2013189. doi: 10.1111\/bpa.12110","journal-title":"Brain Pathol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0596-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T15:36:42Z","timestamp":1498232202000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0596-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,15]]},"article-number":"227"}}